ARMS2 and age-related macular degeneration: In this work the authors evaluated the influence of the Y402H CFH and the A69S ARMS2 polymorphisms on the response to treatment with Age-Related Eye Disease Study (AREDS) formulation (Zinc, β-carotene, Vitamin C and E), in reducing risk progression towards advanced stages of AMD.